NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT02837042 2022-06-21Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaUniversity of Alabama at BirminghamPhase 2 Terminated6 enrolled 10 charts